Reactive oxygen species (ROS) have been shown to up-regulate expression of profibrotic genes, such as col2a1, col1a1, and fn1, thereby resulting in direct extracellular matrix deposition in a transgenic mouse model, and resulting in cardiac hypertrophy [32]. Here, FN1 is linked to cardiac hypertrophy.